Ginkgo Bioworks Aktie News

BOSTON--(BUSINESS WIRE)--Ginkgo Bioworks (NYSE: DNA) gab heute bekannt, dass sein Angebot Ginkgo Datapoints eine neue Vereinbarung mit Lilly TuneLab, einer kollaborativen AI/ML-Wirkstoffentdeckungsplattform von Eli Lilly and Company (Lilly), geschlossen hat. TuneLab fördert Biotech-Innovationen, indem es teilnehmenden Unternehmen den Zugang zu AI/ML-Wirkstoffentdeckungsmodellen ermöglicht, die ...

BOSTON--(BUSINESS WIRE)--Ginkgo Bioworks (NYSE: DNA) gab heute bekannt, dass dem Unternehmen ein Unterauftrag von bis zu 17,5 Mio. USD im Rahmen des GIVE‑Programms (Genetic Medicines and Individualized Manufacturing for Everyone) der Advanced Research Projects Agency for Health (ARPA‑H) erteilt wurde. Ginkgo wird als Unterauftragnehmer für den Hauptauftragnehmer Waterfall Scientific, Inc. an ES...

New co-developed product delivers a complete Tier 1 ADME panel coupled with best-in-class AI-driven human pharmacokinetic (PK) projection and integrated compound management —enabling scientists to make lead-optimization-quality decisions starting in hit identification BOSTON, May 26, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced that its Datapoints offering is launching ADME-...

Ginkgo Bioworks NYSE: DNA said it is sharpening its 2026 focus on autonomous laboratories after completing the divestiture of its biosecurity business and reporting lower year-over-year cash burn in the first quarter.

Ginkgo provides an update on its first quarter financial results following the divestiture of its Biosecurity business BOSTON, May 7, 2026 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced its results for the first quarter of 2026 that ended March 31, 2026. The update, including a webcast slide presentation with additional details on the first quarter, as well...

Presentation and Q&A session scheduled for post-market on Thursday, May 7, 2026 BOSTON, April 30, 2026 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced that it plans to host a presentation and Q&A session reviewing business performance for the first quarter ended March 31, 2026, on Thursday, May 7, 2026, beginning at 4:30 p.m. ET. The presentation details and...